Propranolol Administration and Prevention of Child PTSD in Child Trauma Victims
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Twenty-nine pediatric injury patients (ages 10-18) at risk for PTSD were randomly assigned to
receive either propranolol or placebo in a double-blind placebo controlled design. Medication
was initiated within 12 hours of hospital admission. At 6-weeks, child PTSD symptoms and
heart rate (HR) during trauma recall were assessed. We hypothesized that participants who
received propranolol would report fewer PTSD symptoms and have lower heart rates than those
who received placebo.